Cancer & Tumor Markers Flashcards

1
Q

What is the clinical utility for Prostate Specific Antigen (PSA)?

A

Prostate Cancer (PC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the non-age related range for PC screening?

A

< 4 ng/mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

When is a biopsy recommended for a PSA? [Hint: think of the range]

A

PSA ranging 4-9 ng/mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is PSA density (PSAD)?

A

This is when you divide PSA by prostate volume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

If PSAD is increased, what would that mean?

A

That would mean the patient is a greater risk of having PC then BPH (PSA&raquo_space; BPH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the two common types (not all inclusive) of molecular forms of PSA?

A
free PSA (fPSA) [ranging from 30-40%]
complexed PSA (cPSA) [ranging from 50-70%]
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is PSA velocity?

A

Refers to rate of increase in PSA levels over time

- Faster rate of rise could suggest PC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How would cPSA affect PC?

A

If cPSA has a linear relationship, it would signify PC (cPSA increased, PC would be more at risk)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How would fPSA affect PC?

A

If fPSA has an inverse relationship, it would signify PC

fPSA decreased, PC would be more at risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which of the following is true regarding a PSA statement?

a. Slower rate of PSA velocity is suggestive of PC
b. PSA screening for PC is < 4 ng/mL
c. The majority of serum PSA is unbound to plasma proteins
d. A reduced PSA density is associated with PC

A

b. PSA screening for PC is < 4 ng/mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is carcinoembryonic antigen (CEA) helpful for?

A
It's helpful for monitoring treatment in:
- Colon cancer
- Breast cancer
It's helpful for staging/prognosis in:
- Colon cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is cancer antigen 15-3 (CA 15-3) helpful for?

A

It’s helpful for staging/prognosis & monitoring treatment in:
- Breast cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is cancer antigen 27.29 (CA 27.29) helpful for?

A

It’s helpful for staging/prognosis & monitoring treatment in:
- Breast cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is cancer antigen 125 (CA 125) helpful for?

A

It is helpful for staging/prognosis & monitoring treatment in:
- Ovarian cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is human chronic gonadotropin (hCG) helpful for?

A

It is helpful for staging/prognosis, monitoring AND diagnosis in:
- Germ cell tumors (ovaries/testis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is cancer antigen 19-9 (CA 19-9) helpful for?

A

It is helpful for staging/prognosis & monitoring treatment in:
- Pancreatic cancer

17
Q

What is alpha fetoprotein helpful for? HINT: two things

A
It is helpful for staging/prognosis, monitoring treatment  and diagnosis in:
- Hepatocellular carcinoma
- Testicular cancer
It is also helpful for screening in"
- Hepatocellular carcinoma
18
Q

What is Beta-2 Microglobulin (B2M) helpful for?

A

It is helpful for staging/prognosis, monitoring treatment in:
- Multiple myeloma

19
Q

Which of the following serum tumor markers are used to stage and monitor treatment in breast cancer?

a. CA 15-3 and CA 125
b. CA 15-3 and CA 27.29
c. CA 27.29 and CA 125
d. CA 27. 29 and CA 19-9

A

b. CA 15-3 and CA 27.29

20
Q

Which of the following is utilized in the diagnosis of germ cell tumors of the ovaries and testes?

a. CEA
b. B2M
c. CEA
d. hCG

A

d. hCG

21
Q

What is the clinical utility of estrogen (ER) and Progesterone (PR)?

A

Breast cancer

22
Q

What would be needed if ER and PR become positive in breast cancer?

A

Treatment would be needed, such as:

- tamoxifen

23
Q

What is the clinical utility of human epidermal growth factor receptor 2 (HER2)?

A

Breast cancer

24
Q

What would be needed if HER2 becomes positive?

A

Treatment would be needed, specifically anti-HER2 such as:

- trastuzumab

25
Q

What is the clinical utility of BCR-ABL?

A

Chronic myelogenous leukemia

26
Q

If BCR-ABL is positive, what would be needed?

A

Treatment would be needed, such as a TK inhibitor:

- imatinib

27
Q

Which of the following predicts the likelihood that breast cancer will respond to hormonal therapies?

a. HER2
b. EGFR
c. BCR-ABL
d. ER & PR

A

d. ER & PR

28
Q

What is the clinical utility for epidermal growth factor receptor (EGFR)?

A

Pulmonary Adenocarcinoma (PA)

29
Q

What would be needed if mutation occurs in response to EGFRs?

A

TK inhibitors would needed for treatment

- eroltinib

30
Q

What is the clinical utility for V-Ki-Ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRas)?

A

Colorectal cancer

31
Q

What would be needed if a wild-type (nonmutated) occurs in response to KRas?

A

anti-EGFR treatment would be needed

- cetuximab

32
Q

What is the clinical utility for V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF)?

A

Melanoma

33
Q

What would be needed if mutation occurs in response to BRAF?

A

BRAF inhibitors would be needed, such as:

- vemurafenib

34
Q

Are BRAF inhibitors recommended for wild-type tumors (nonmutated tumors)?

A

No, they are not recommended

35
Q

What is the clinical utility for anaplastic lymphoma kinase (ALK)?

A

Pulmonary Adenocarcinoma (PA)

36
Q

If abnormal fusion protein (EML4-ALK) occurs in response to the ALK, what treatment would be needed?

A

ALK inhibitors would be needed, such as:

- crizotinib

37
Q

Which mutation predicts lung cancer responsiveness to therapy with erlotinib?

A

EGFR

38
Q

RS, is a 61 yo male, diagnosed with colorectal cancer. Genetic testing reveals a wild-type tumor. Which treatment would be recommended?

A

Cetuximab